Skip to main content
. 2021 Nov 18;59(12):e01580-21. doi: 10.1128/JCM.01580-21

FIG 1.

FIG 1

Schematic representation of developing the cELISA to detect PRRSV antibodies using the nanobody-HRP fusion proteins as a reagent. (A) The platform for stably expressing nanobody-HRP fusion proteins using HEK293S cells. (B) Competitive ELISA for using the fusion protein as a reagent.